This section investigates immune activation by biotherapeutic medicines and vaccines with a special interest in tumour immunotherapy.
Our standardisation and control work in the areas of immunotoxicology and pyrogenic proinflammatory activities is supported by research projects.
We also develop reference materials for standardising diagnostic flow cytometry assays.
This section can be divided into 3 groups listed below. We also conduct research relating to tumour immunotherapy.